Pulmonary Cell News Volume 12.31 | Aug 10 2023

    0
    13







    2023-08-10 | PULCN 12.31


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 12.31 – 10 August, 2023
    TOP STORY

    Mitochondrial Integrated Stress Response Controls Lung Epithelial Cell Fate

    Researchers reported that deleting the mitochondrial electron transport chain complex I subunit Ndufs2 in lung epithelial cells during mouse gestation led to death during postnatal alveolar development.
    [Nature]

    Full ArticlePress Release
    Tumors Are 3D. Shouldn't Your In Vitro Model Be? Learn More.
    PUBLICATIONSRanked by the impact factor of the journal

    Loss of microRNA-30a and Sex-Specific Effects on the Neonatal Hyperoxic Lung Injury

    Investigators tested the hypothesis that loss of miR-30a would result in male and female mice experiencing similar impairments in alveolarization and angiogenesis under hyperoxic conditions.
    [Biology Of Sex Differences]

    Full Article

    Overactivated Epithelial NF-κB Disrupts Lung Development in Congenital Diaphragmatic Hernia

    Using sections and hypoplastic lung explant cultures from the nitrofen rat model of congenital diaphragmatic hernia (CHD) and human fetal CDH lungs, researchers demonstrated that NF-κB and its downstream transcriptional targets are hyperactive during abnormal lung formation in CDH.
    [American Journal Of Respiratory Cell And Molecular Biology]

    Abstract

    Regulating NLRP3 Inflammasome–Induced Pyroptosis via Nrf2: TBHQ Limits Hyperoxia-Induced Lung Injury in a Mouse Model of Bronchopulmonary Dysplasia

    Scientists established a bronchopulmonary dysplasia mouse model to investigate the effects of tert-butylhydroquinone (TBHQ), an nuclear factor e2–related factor 2 (Nrf2) activator, on oxidative stress injury, pyroptosis, NLRP3 inflammasome activation, and alveolar development.
    [Inflammation]

    Full Article

    Ginsenoside Rg3 Attenuates Pulmonary Fibrosis by Inhibiting Endothelial to Mesenchymal Transition

    Investigators hypothesized that Ginsenoside Rg3 may be a potential therapeutic agent for pulmonary fibrosis-targeting endothelial-to-mesenchymal transition.
    [Animal Cells And Systems]

    Full Article

    ADPGK-AS1 Long Noncoding RNA Switches Macrophage Metabolic and Phenotypic State to Promote Lung Cancer Growth

    Scientists found that the lncRNA ADPGK-AS1 was substantially upregulated in artificially induced M2-like human macrophages, macrophages exposed to lung cancer cells in vitro, and tumor-associated macrophages from human lung cancer tissue.
    [EMBO Journal]

    Full ArticleGraphical Abstract

    Protein Exaptation by Endogenous Retroviral Elements Shapes Tumor Cell Senescence and Downstream Immune Signaling

    An increased expression of calbindin reduced CXCL8 chemokine production and downstream neutrophil recruitment in lung squamous cell carcinoma tumor cells.
    [Cancer Research]

    Abstract

    Inhibition of EZH2 Alleviates SAHA-Induced Senescence-Associated Secretion Phenotype in Small Cell Lung Cancer Cells

    Researchers reported that SCLC cells treated with an FDA-approved HDAC inhibitor SAHA underwent senescence and displayed remarkable senescence-associated secretion phenotype. In particular, SAHA promoted the formation of cytoplasmic chromatin fragments in SCLC cells.
    [Cell Death Discovery]

    Full Article

    IL-1β Is Involved in Docetaxel Chemoresistance by Regulating the Formation of Polyploid Giant Cancer Cells in Non-Small Cell Lung Cancer

    Investigators found that docetaxel induced G2/M cell cycle arrest and cell death in A549 and NCI-H1299 cells. However, many cells remained alive and became polyploid giant cancer cells by decreasing the expression of key regulatory proteins related to the cell cycle and proliferation.
    [Scientific Reports]

    Full Article
    On-demand Webinar on Studying Cystic Fibrosis using Primary Human Nasal Epithelial Cells - Watch Now
    REVIEWS

    Exploring Redox Imbalance and Inflammation for Asthma Therapy

    The authors identify targets of redox imbalance and inflammation that could be explored to create effective treatments for asthma.
    [Molecular Biology Reports]

    Abstract
    INDUSTRY AND POLICY NEWS

    ImPact Biotech Receives FDA Clearance for Padeliporfin VTP Phase I Clinical Program in Peripheral Lung Cancer

    The planned Phase I/Ib, safety, feasibility, and light dose titration study followed by further study of therapeutic ablation effects, was designed as a multicenter, open-label study of Padeliporfin Vascular Targeted Photodynamic for lung tumor ablation in patients with Peripheral Lung Cancer.
    [ImPact Biotech (Globe Newswire)]

    Press Release
    FEATURED EVENT

    89th Harden Conference – Proteoglycans: Matrix Master Regulators 2023

    September 4 – 7, 2023
    Surrey, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Researcher – Pulmonary Research

    University of Maryland – Baltimore, Maryland, United States

    Principal Investigators – Molecular Cell Science

    Center for Excellence in Molecular Cell Science – Shanghai, China

    Postdoctoral Scientist – Cancer Research Cluster

    Cedars-Sinai – Los Angeles, California, United States

    Research Technician – Pediatrics Allergy & Pulmonary Medicine

    University of Washington – Medical Lake, Washington, United States

    Research Assistant – Biomedicine

    IRB Barcelona – Barcelona, Spain

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter